Cti tracker

The Contraceptive Technology Innovation Tracker—CTI Tracker—houses information on potential contraceptive leads in early development, products in pre-clinical and clinical development, and products with single-country regulatory approval. The Tracker reports on both active development platforms and inactive R&D.

Contraceptive Pipeline Baseline Report ⬇ Export Database

For more information about contraceptive R&D, visit our partner databases

Show Filters
Active
Last updated: January 7, 2026
Venova Barrier Device
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Barrier
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Venova Technologies
Active
Last updated: January 7, 2026
Vas Deferens RISUG

Reversible Inhibition of Sperm Under Guidance (RISUG)

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Vas Deferens
  • Intended Duration: Long-Acting
  • Development Stage: Phase III
  • Developer(s)/Researcher(s): Indian Council for Medical Research, Indian Institute of Technology, Kharagpur, University of Rajasthan
Active
Last updated: January 7, 2026
Tenofovir + Levonorgestrel Vaginal Ring
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Vaginal Ring
  • Intended Duration: Short-Acting
  • Development Stage: Phase II
  • Developer(s)/Researcher(s): CONRAD
Active
Last updated: January 7, 2026
STK33 Inhibitors

CDD-2807

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Baylor College of Medicine, University of Minnesota
Active
Last updated: January 7, 2026
SMRT Inhibitors

MS-275, SNDX-275, Entinostat

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Salk Institute for Biological Studies, University of California, Berkeley, University of California, Irvine, Utrecht University, University of Sydney
Active
Last updated: January 7, 2026
SMART Polymer Non-Steroidal Contraceptive Device
  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Vaginal - Other
  • Intended Duration: Not Yet Determined
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): St. Louis College of Pharmacy, Washington University, Brigham and Women's Hospital, University of Cincinnati, Yale University
Active
Last updated: January 7, 2026
SLO3 Inhibitors

VU0546110, VU6032735

  • User: Female
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Not Yet Determined
  • Development Stage: Discovery & Early Development
  • Developer(s)/Researcher(s): Washington University, Vanderbilt University
Active
Last updated: January 7, 2026
SCHIELD Biodegradable Implant MPT
  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Subdermal
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): RTI International
Active
Last updated: January 7, 2026
sAC Inhibitors

TDI-11861, TDI-10229

  • User: Male
  • Hormonal: Non-Hormonal
  • Delivery Type: Not Yet Determined
  • Intended Duration: Pericoital
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): Weill Cornell Medicine, Sacyl Pharmaceuticals
Active
Last updated: January 7, 2026
Refillable Nanofluidic Subcutaneous Implant

ENG + ISL NanoMPI

  • User: Female
  • Hormonal: Hormonal
  • Delivery Type: Subdermal
  • Intended Duration: Long-Acting
  • Development Stage: Pre-Clinical
  • Developer(s)/Researcher(s): University of Washington, Methodist Hospital Research Institute